'en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire'
(id=6890146 ; fe=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=6457 creation date=2017-06-25 touchdate=2024-09-20 01:47:38.000)

≈ 281 relations sortantes en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 29 / 1 -> en:instrumental activities of daily living n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:instrumental activities of daily living | rel=r_associated | relid=0 | w=29 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 28 / 0.966 -> cancer n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=cancer | rel=r_associated | relid=0 | w=28 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 28 / 0.966 -> en:fact-h&n questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-h&n questionnaire | rel=r_associated | relid=0 | w=28 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 27 / 0.931 -> thérapie n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=thérapie | rel=r_associated | relid=0 | w=27 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:12-item multiple sclerosis walking scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:12-item multiple sclerosis walking scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:6-item orientation-memory-concentration test n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:6-item orientation-memory-concentration test | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:abnormal involuntary movement scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:abnormal involuntary movement scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:activities of daily living dimension of functioning questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:activities of daily living dimension of functioning questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:adhd rating scale-iv home version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:adhd rating scale-iv home version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:adult hope scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:adult hope scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:airway questionnaire 20 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:airway questionnaire 20 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alcohol use disorder identification test alcohol consumption questions questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alcohol use disorder identification test alcohol consumption questions questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alcohol use disorder identification test self-report version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alcohol use disorder identification test self-report version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alzheimer's disease cooperative study activities of daily living inventory questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alzheimer's disease cooperative study activities of daily living inventory questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:alzheimer's disease cooperative study-clinical global impression of change questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:alzheimer's disease cooperative study-clinical global impression of change questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:arizona sexual experiences scale-female version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:arizona sexual experiences scale-female version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:arizona sexual experiences scale-male version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:arizona sexual experiences scale-male version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:assessment of survivor concerns n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:assessment of survivor concerns | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:asthma control questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:asthma control questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:asthma control test questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:asthma control test questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:asthma quality of life questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:asthma quality of life questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:attitudes and preferences questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:attitudes and preferences questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:australia-modified karnofsky performance scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:australia-modified karnofsky performance scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:barnes akathisia rating scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:barnes akathisia rating scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:baseline dyspnea index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:baseline dyspnea index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:bladder control scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:bladder control scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:borg category-ratio 10 scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:borg category-ratio 10 scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:borg category-ratio 10 scale score 11 point scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:borg category-ratio 10 scale score 11 point scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:borg scale rating of perceived exertion questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:borg scale rating of perceived exertion questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:bowel control scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:bowel control scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:breast cancer prevention trial symptom scales n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:breast cancer prevention trial symptom scales | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:breast cancer treatment outcomes scale-cosmetic status n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:breast cancer treatment outcomes scale-cosmetic status | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:breast lymphedema symptom survey n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:breast lymphedema symptom survey | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:brief pain inventory questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:brief pain inventory questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:brief pain inventory short form questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:brief pain inventory short form questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:brief psychiatric rating scale a questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:brief psychiatric rating scale a questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:california verbal learning test - second edition n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:california verbal learning test - second edition | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:cancer patient tobacco use questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:cancer patient tobacco use questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:cancer rehabilitation evaluation system for research n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:cancer rehabilitation evaluation system for research | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:cdisc qrs terminology n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:cdisc qrs terminology | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:cdisc questionnaire category terminology n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:cdisc questionnaire category terminology | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:cdisc questionnaire terminology n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:cdisc questionnaire terminology | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:cdisc sdtm terminology n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:cdisc sdtm terminology | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:center for epidemiologic studies depression scale revised n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:center for epidemiologic studies depression scale revised | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:charlson comorbidity index chart review version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:charlson comorbidity index chart review version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:child health questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:child health questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:childhood health assessment questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:childhood health assessment questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:children's dermatology life quality index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:children's dermatology life quality index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:children's memory scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:children's memory scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:chronic respiratory questionnaire self-administered standardized format n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:chronic respiratory questionnaire self-administered standardized format | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:clinical copd questionnaire 1 week version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:clinical copd questionnaire 1 week version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:clinical copd questionnaire 24 hour version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:clinical copd questionnaire 24 hour version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:clinical data interchange standards consortium terminology n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:clinical dementia rating questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:clinical dementia rating questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:clinical global impression questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:clinical global impression questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:clinical opiate withdrawal scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:clinical opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale already enrolled subjects questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale already enrolled subjects questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale baseline questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale baseline questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale baseline/screening version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale baseline/screening version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale children's baseline questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale children's baseline questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale children's baseline/screening questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale children's baseline/screening questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale children's since last visit questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale children's since last visit questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale lifetime/recent version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale lifetime/recent version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale screening questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale screening questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:columbia-suicide severity rating scale since last visit questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:columbia-suicide severity rating scale since last visit questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:contemplation ladder for smoking cessation n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:contemplation ladder for smoking cessation | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:copd assessment test questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:copd assessment test questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:craig handicap assessment and reporting technique - short form paper version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:craig handicap assessment and reporting technique - short form paper version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:craig handicap assessment and reporting technique-short form interview version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:craig handicap assessment and reporting technique-short form interview version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:current opioid misuse measure questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:current opioid misuse measure questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:dermatology life quality index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:dermatology life quality index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:disability assessment for dementia questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:disability assessment for dementia questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:disability rating scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:disability rating scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:disease steps questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:disease steps questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:duke psychosocial questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:duke psychosocial questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:eastern cooperative oncology group performance status questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:eastern cooperative oncology group performance status questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:eortc/rotg late radiation morbidity scoring criteria n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:eortc/rotg late radiation morbidity scoring criteria | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:epworth sleepiness scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:epworth sleepiness scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:european organization for research and treatment of cancer quality of life questionnaire core 30 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:european organization for research and treatment of cancer quality of life questionnaire core 30 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:european quality of life five dimension five level scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:european quality of life five dimension five level scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:european quality of life five dimension three level questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:european quality of life five dimension three level questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:european quality of life five dimension three level youth questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:european quality of life five dimension three level youth questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:expanded disability rating scale - postacute interview caregiver version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:expanded disability rating scale - postacute interview caregiver version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:expanded disability rating scale - postacute interview survivor version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:expanded disability rating scale - postacute interview survivor version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:expanded prostate cancer index composite n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:expanded prostate cancer index composite | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:expanded prostate cancer index composite for clinical practice questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:expanded prostate cancer index composite for clinical practice questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:expanded prostate cancer index composite, sexual medications/devices supplement n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:expanded prostate cancer index composite, sexual medications/devices supplement | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:extended glasgow outcome scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:extended glasgow outcome scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:faact questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:faact questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:faces pain scale revised questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:faces pain scale revised questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-an questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-an questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-b questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-b questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-b+4 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-b+4 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-bl questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-bl questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-bmt questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-bmt questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-bp questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-bp questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-br questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-br questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-brm questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-brm questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-c questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-c questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-cns questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-cns questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-cognitive function n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-cognitive function | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-cx questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-cx questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-e questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-e questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-en questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-en questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-es questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-es questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-g questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-g questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-ga questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-ga questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-hep questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-hep questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-l questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-l questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-leu questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-leu questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-m questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-m questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-mm questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-mm questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-n questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-n questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-np questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-np questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-o questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-o questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-p questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-p questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-taxane questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-taxane questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact-th11 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact-th11 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fact/gog-ntx questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fact/gog-ntx questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fait-u questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fait-u questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:fksi-15 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:fksi-15 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:follow-up embodiment/outcomes questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:follow-up embodiment/outcomes questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:follow-up outcome expectations questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:follow-up outcome expectations questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional activities questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional activities questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional activities questionnaire-nacc version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional activities questionnaire-nacc version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of cancer therapy-breast version 4 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of cancer therapy-breast version 4 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of cancer therapy-general version 4 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of cancer therapy-general version 4 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of cancer therapy-ovarian symptom index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of cancer therapy-ovarian symptom index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of cancer therapy-prostate version 4 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of cancer therapy-prostate version 4 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of human immunodeficiency virus infection n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of human immunodeficiency virus infection | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:functional assessment of multiple sclerosis questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:functional assessment of multiple sclerosis questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:generalized anxiety disorder - 7 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:generalized anxiety disorder - 7 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:generalized anxiety disorder questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:generalized anxiety disorder questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:geriatric depression scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:geriatric depression scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:geriatric depression scale short form questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:geriatric depression scale short form questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:global rating of change in joint pain and stiffness questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:global rating of change in joint pain and stiffness questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:health assessment questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:health assessment questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:health assessment questionnaire disability index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:health assessment questionnaire disability index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:health assessment questionnaire-ii n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:health assessment questionnaire-ii | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:healthy volunteer medical history questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:healthy volunteer medical history questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hearing handicap inventory for the elderly, screening version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hearing handicap inventory for the elderly, screening version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire adult version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire adult version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire children's long version age group i n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group i | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire children's long version age group ii n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group ii | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire children's long version age group iii n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire children's long version age group iii | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire children's short version age group i n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire children's short version age group i | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire children's short version age group ii/iii n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire children's short version age group ii/iii | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire parent's long version age group i n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire parent's long version age group i | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire parent's long version age group ii n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire parent's long version age group ii | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hemophilia quality of life questionnaire parent's long version age group iii n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hemophilia quality of life questionnaire parent's long version age group iii | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:hospital anxiety and depression scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:hospital anxiety and depression scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:human activity profile n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:human activity profile | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:impact of visual impairment scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:impact of visual impairment scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:influenza intensity and impact questionnaire once daily version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:influenza intensity and impact questionnaire once daily version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:influenza intensity and impact questionnaire twice daily version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:influenza intensity and impact questionnaire twice daily version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:initial outcome satisfaction questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:initial outcome satisfaction questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:international index of erectile function questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:international index of erectile function questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:karnofsky performance status scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:karnofsky performance status scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:kaufman assessment battery for children n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:kaufman assessment battery for children | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:kurtzke expanded disability status scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:kurtzke expanded disability status scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:kurtzke functional systems scores questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:kurtzke functional systems scores questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:list of threatening experiences questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:list of threatening experiences questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:lymphedema and breast cancer questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:lymphedema and breast cancer questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:mayo-portland adaptability inventory-4 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:mayo-portland adaptability inventory-4 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:md anderson dysphagia inventory n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:md anderson dysphagia inventory | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:md anderson symptom inventory - brain tumor n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:md anderson symptom inventory - brain tumor | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:md anderson symptom inventory - core n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:md anderson symptom inventory - core | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:md anderson symptom inventory - head and neck n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:md anderson symptom inventory - head and neck | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:md anderson symptom inventory - lung chemoradiation n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:md anderson symptom inventory - lung chemoradiation | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:md anderson symptom inventory - spine tumor n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:md anderson symptom inventory - spine tumor | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:medical outcomes study physical functioning scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:medical outcomes study physical functioning scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:medical outcomes study social activities n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:medical outcomes study social activities | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:medical outcomes study social support survey n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:medical outcomes study social support survey | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:medical outcomes study your feelings questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:medical outcomes study your feelings questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:memorial symptom assessment scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:memorial symptom assessment scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:memorial symptom assessment scale - short form n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:memorial symptom assessment scale - short form | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:menstrual distress questionnaire form-t (today) n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:menstrual distress questionnaire form-t (today) | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:michigan neuropathy screening instrument questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:michigan neuropathy screening instrument questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:mini-mental status exam n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:mini-mental status exam | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:modified barium swallow impairment profile n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:modified barium swallow impairment profile | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:modified fatigue impact scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:modified fatigue impact scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:modified hachinski ischemic scale-nacc version questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:modified hachinski ischemic scale-nacc version questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:modified medical research council dyspnea scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:modified medical research council dyspnea scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:modified rankin scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:modified rankin scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:montgomery-asberg depression rating scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:montgomery-asberg depression rating scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:movement disorder society unified parkinson's disease rating scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:movement disorder society unified parkinson's disease rating scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:multidimensional body-self relations questionnaire appearance orientation n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:multidimensional body-self relations questionnaire appearance orientation | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:multinational association of supportive care in cancer antiemesis tool n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:multinational association of supportive care in cancer antiemesis tool | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:multiple sclerosis impact scale version 1 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:multiple sclerosis impact scale version 1 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:multiple sclerosis impact scale version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:multiple sclerosis impact scale version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:multiple sclerosis quality of life-54 instrument questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:multiple sclerosis quality of life-54 instrument questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:myeloproliferative neoplasm symptom assessment form n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:myeloproliferative neoplasm symptom assessment form | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:neck dissection impairment index n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:neck dissection impairment index | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:neuropathic pain scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:neuropathic pain scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:neuropsychiatric inventory questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:neuropsychiatric inventory questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:nurses' health study ii activity and inactivity questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:nurses' health study ii activity and inactivity questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:ocular comfort index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:ocular comfort index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:older americans resource scale multidimensional functional assessment questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:older americans resource scale multidimensional functional assessment questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:older americans resources and services comorbidity scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:older americans resources and services comorbidity scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:osoba nausea and emesis module n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:osoba nausea and emesis module | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:outcome satisfaction questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:outcome satisfaction questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:parkinson's disease quality of life scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:parkinson's disease quality of life scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient determined disease steps questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient determined disease steps questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient health questionnaire - 15 item n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient health questionnaire - 15 item | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient health questionnaire - 9 item n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient health questionnaire - 9 item | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient health questionnaire screener version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient health questionnaire screener version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient health questionnaire-2 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient health questionnaire-2 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient reported outcomes version of ctcae n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient reported outcomes version of ctcae | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:patient satisfaction questionnaire short form n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:patient satisfaction questionnaire short form | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:pediatric quality of life inventory n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:pediatric quality of life inventory | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:perceived stress scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:perceived stress scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:primary care evaluation of mental disorders patient health questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:primary care evaluation of mental disorders patient health questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:prognosis treatment and perceptions questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:prognosis treatment and perceptions questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:promis adult sleep-related impairment item bank n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:promis adult sleep-related impairment item bank | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:prostate cancer specific quality of life instrument questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:prostate cancer specific quality of life instrument questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:quality of life questionnaire - testicular cancer 26 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:quality of life questionnaire - testicular cancer 26 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:quality of life questionnaire-multiple myeloma 20 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:quality of life questionnaire-multiple myeloma 20 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:rand 36-item health survey 1.0 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:rand 36-item health survey 1.0 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:raven's progressive matrices n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:raven's progressive matrices | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:rcc symptom index n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:rcc symptom index | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:revised fibromyalgia impact questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:revised fibromyalgia impact questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:rivermead post-concussion symptoms questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:rivermead post-concussion symptoms questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:roland morris disability questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:roland morris disability questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:satisfaction with life scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:satisfaction with life scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:screener and opioid assessment for patients with pain revised questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:screener and opioid assessment for patients with pain revised questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:sf-12 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:sf-12 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:sf-36 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:sf-36 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:sheehan disability scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:sheehan disability scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:short opiate withdrawal scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:short opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:short-form mcgill pain questionnaire-2 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:short-form mcgill pain questionnaire-2 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:shortness of breath with daily activities questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:shortness of breath with daily activities questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:smoking self-efficacy questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:smoking self-efficacy questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:st. george's respiratory questionnaire past 3 months version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:st. george's respiratory questionnaire past 3 months version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:st. george's respiratory questionnaire past 4 weeks version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:st. george's respiratory questionnaire past 4 weeks version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:standards general clinical global impressions questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:standards general clinical global impressions questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:standards pain intensity questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:standards pain intensity questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:standards pain relief questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:standards pain relief questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:subjective numeracy scale n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:subjective numeracy scale | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:subjective opiate withdrawal scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:subjective opiate withdrawal scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:symptom impact questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:symptom impact questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:taps tool - interviewer version n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:taps tool - interviewer version | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:ten promis global health questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:ten promis global health questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:the expanded prostate cancer index composite short form questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:the expanded prostate cancer index composite short form questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:the oswestry disability index version 2.1a questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:the oswestry disability index version 2.1a questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:the overactive bladder questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:the overactive bladder questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:the overactive bladder questionnaire short form n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:the overactive bladder questionnaire short form | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:transition dyspnea index questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:transition dyspnea index questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:treatment satisfaction questionnaire for medication n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:treatment satisfaction questionnaire for medication | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:unified parkinson's disease rating scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:unified parkinson's disease rating scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:university of washington quality of life scale, version 4 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:university of washington quality of life scale, version 4 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:urgency perception scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:urgency perception scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:visual functioning questionnaire 25-interviewer administered format version 2000 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:visual functioning questionnaire 25-interviewer administered format version 2000 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:visual functioning questionnaire 25-self administered format version 2000 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:visual functioning questionnaire 25-self administered format version 2000 | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:was it worth it questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:was it worth it questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:wechsler memory scale - fourth edition n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:wechsler memory scale - fourth edition | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:woodcock-johnson tests of cognitive abilities n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:woodcock-johnson tests of cognitive abilities | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:work limitations questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:work limitations questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:work productivity and activity impairment general health v2.0 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:work productivity and activity impairment general health v2.0 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:work productivity and activity impairment specific health problems version 2.0 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:work productivity and activity impairment specific health problems version 2.0 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> en:young mania rating scale questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:young mania rating scale questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 26 / 0.897 -> rein n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=rein | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 25 / 0.862 -> en:national n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:national | rel=r_associated | relid=0 | w=25 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 20 / 0.69 -> en:aya-hears n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:aya-hears | rel=r_associated | relid=0 | w=20 en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire -- r_associated #0: 20 / 0.69 -> en:brief psychiatric rating scale - version 4 n1=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | n2=en:brief psychiatric rating scale - version 4 | rel=r_associated | relid=0 | w=20

≈ 280 relations entrantes en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire --- r_associated #0: 42 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired lifetime/recent questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=42 en:subjective numeracy scale --- r_associated #0: 42 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:subjective numeracy scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=42 en:cdisc sdtm terminology --- r_associated #0: 39 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:cdisc sdtm terminology | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=39 en:revised fibromyalgia impact questionnaire --- r_associated #0: 39 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:revised fibromyalgia impact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=39 en:patient reported outcomes version of ctcae --- r_associated #0: 38 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient reported outcomes version of ctcae | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=38 en:smoking self-efficacy questionnaire --- r_associated #0: 38 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:smoking self-efficacy questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=38 en:woodcock-johnson tests of cognitive abilities --- r_associated #0: 38 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:woodcock-johnson tests of cognitive abilities | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=38 en:bowel control scale questionnaire --- r_associated #0: 37 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:bowel control scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=37 en:primary care evaluation of mental disorders patient health questionnaire --- r_associated #0: 37 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:primary care evaluation of mental disorders patient health questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=37 en:adult hope scale --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:adult hope scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:alzheimer's disease cooperative study-clinical global impression of change questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alzheimer's disease cooperative study-clinical global impression of change questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:clinical global impression questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:clinical global impression questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired - since last visit - clinical questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:fact-b questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-b questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:fksi-15 questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fksi-15 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:functional assessment of cancer therapy-ovarian symptom index questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of cancer therapy-ovarian symptom index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:hearing handicap inventory for the elderly, screening version --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hearing handicap inventory for the elderly, screening version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:ocular comfort index questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:ocular comfort index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:older americans resources and services comorbidity scale --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:older americans resources and services comorbidity scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:satisfaction with life scale questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:satisfaction with life scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:shortness of breath with daily activities questionnaire --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:shortness of breath with daily activities questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:wechsler memory scale - fourth edition --- r_associated #0: 35 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:wechsler memory scale - fourth edition | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=35 en:breast cancer treatment outcomes scale-cosmetic status --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:breast cancer treatment outcomes scale-cosmetic status | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:brief psychiatric rating scale - version 4 --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:brief psychiatric rating scale - version 4 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:eortc/rotg late radiation morbidity scoring criteria --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:eortc/rotg late radiation morbidity scoring criteria | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:extended glasgow outcome scale questionnaire --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:extended glasgow outcome scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:outcome satisfaction questionnaire --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:outcome satisfaction questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:patient health questionnaire - 9 item --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient health questionnaire - 9 item | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:subjective opiate withdrawal scale questionnaire --- r_associated #0: 34 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:subjective opiate withdrawal scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=34 en:cdisc questionnaire terminology --- r_associated #0: 32 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:cdisc questionnaire terminology | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=32 en:modified barium swallow impairment profile --- r_associated #0: 32 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:modified barium swallow impairment profile | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=32 en:osoba nausea and emesis module --- r_associated #0: 32 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:osoba nausea and emesis module | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=32 en:the expanded prostate cancer index composite short form questionnaire --- r_associated #0: 32 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:the expanded prostate cancer index composite short form questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=32 en:bladder control scale questionnaire --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:bladder control scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:clinical dementia rating questionnaire --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:clinical dementia rating questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:functional assessment of cancer therapy-breast version 4 questionnaire --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of cancer therapy-breast version 4 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:impact of visual impairment scale questionnaire --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:impact of visual impairment scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:md anderson symptom inventory - core --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:md anderson symptom inventory - core | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:visual functioning questionnaire 25-interviewer administered format version 2000 --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:visual functioning questionnaire 25-interviewer administered format version 2000 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire --- r_associated #0: 31 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 visual analog scale format questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=31 en:alcohol use disorder identification test self-report version questionnaire --- r_associated #0: 30 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alcohol use disorder identification test self-report version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=30 en:aya-hears --- r_associated #0: 30 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:aya-hears | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=30 en:columbia-suicide severity rating scale baseline/screening version questionnaire --- r_associated #0: 30 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale baseline/screening version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=30 en:instrumental activities of daily living --- r_associated #0: 30 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:instrumental activities of daily living | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=30 en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 --- r_associated #0: 30 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:quality of life questionnaire - gastrointestinal neuroendocrine tumors 21 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=30 en:taps tool - interviewer version --- r_associated #0: 30 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:taps tool - interviewer version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=30 en:borg scale rating of perceived exertion questionnaire --- r_associated #0: 29 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:borg scale rating of perceived exertion questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=29 en:center for epidemiologic studies depression scale revised --- r_associated #0: 29 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:center for epidemiologic studies depression scale revised | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=29 en:child health questionnaire --- r_associated #0: 29 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:child health questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=29 en:fact-n questionnaire --- r_associated #0: 29 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-n questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=29 en:hemophilia quality of life questionnaire children's long version age group ii --- r_associated #0: 29 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire children's long version age group ii | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=29 en:st. george's respiratory questionnaire past 3 months version --- r_associated #0: 28 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:st. george's respiratory questionnaire past 3 months version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=28 en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire --- r_associated #0: 28 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 likert scale format questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=28 en:cdisc qrs terminology --- r_associated #0: 27 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:cdisc qrs terminology | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=27 en:human activity profile --- r_associated #0: 27 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:human activity profile | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=27 en:neuropsychiatric inventory questionnaire --- r_associated #0: 27 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:neuropsychiatric inventory questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=27 en:quality of life questionnaire-multiple myeloma 20 --- r_associated #0: 27 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:quality of life questionnaire-multiple myeloma 20 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=27 en:short-form mcgill pain questionnaire-2 --- r_associated #0: 27 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:short-form mcgill pain questionnaire-2 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=27 en:brief pain inventory short form questionnaire --- r_associated #0: 26 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:brief pain inventory short form questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:clinical data interchange standards consortium terminology --- r_associated #0: 26 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:clinical data interchange standards consortium terminology | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire --- r_associated #0: 26 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-ovarian symptom index-18 version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:university of washington quality of life scale, version 4 --- r_associated #0: 26 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:university of washington quality of life scale, version 4 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:work limitations questionnaire --- r_associated #0: 26 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:work limitations questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:work productivity and activity impairment general health v2.0 questionnaire --- r_associated #0: 26 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:work productivity and activity impairment general health v2.0 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=26 en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire --- r_associated #0: 21 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-bladder symptom index-18 version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=21 cancer --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=cancer | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:12-item multiple sclerosis walking scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:12-item multiple sclerosis walking scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:6-item orientation-memory-concentration test --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:6-item orientation-memory-concentration test | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:abnormal involuntary movement scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:abnormal involuntary movement scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:activities of daily living dimension of functioning questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:activities of daily living dimension of functioning questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:adhd rating scale-iv home version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:adhd rating scale-iv home version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:airway questionnaire 20 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:airway questionnaire 20 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:alcohol use disorder identification test alcohol consumption questions questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alcohol use disorder identification test alcohol consumption questions questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alzheimer's disease assessment scale-cognitive cdisc version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:alzheimer's disease cooperative study activities of daily living inventory questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alzheimer's disease cooperative study activities of daily living inventory questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alzheimer's disease cooperative study-activities of daily living inventory mild cognitive impairment questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:alzheimer's disease cooperative study-activities of daily living inventory severe dementia questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:arizona sexual experiences scale-female version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:arizona sexual experiences scale-female version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:arizona sexual experiences scale-male version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:arizona sexual experiences scale-male version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:assessment of survivor concerns --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:assessment of survivor concerns | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:asthma control questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:asthma control questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:asthma control test questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:asthma control test questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:asthma quality of life questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:asthma quality of life questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:attitudes and preferences questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:attitudes and preferences questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:australia-modified karnofsky performance scale --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:australia-modified karnofsky performance scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:barnes akathisia rating scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:barnes akathisia rating scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:baseline dyspnea index questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:baseline dyspnea index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:borg category-ratio 10 scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:borg category-ratio 10 scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:borg category-ratio 10 scale score 11 point scale --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:borg category-ratio 10 scale score 11 point scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:breast cancer prevention trial symptom scales --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:breast cancer prevention trial symptom scales | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:breast lymphedema symptom survey --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:breast lymphedema symptom survey | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:brief pain inventory questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:brief pain inventory questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:brief psychiatric rating scale a questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:brief psychiatric rating scale a questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:california verbal learning test - second edition --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:california verbal learning test - second edition | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:cancer patient tobacco use questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:cancer patient tobacco use questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:cancer rehabilitation evaluation system for research --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:cancer rehabilitation evaluation system for research | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:cdisc questionnaire category terminology --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:cdisc questionnaire category terminology | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:charlson comorbidity index chart review version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:charlson comorbidity index chart review version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:childhood health assessment questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:childhood health assessment questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:children's dermatology life quality index questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:children's dermatology life quality index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:children's memory scale --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:children's memory scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:chronic respiratory questionnaire self-administered standardized format --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:chronic respiratory questionnaire self-administered standardized format | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:clinical copd questionnaire 1 week version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:clinical copd questionnaire 1 week version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:clinical copd questionnaire 24 hour version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:clinical copd questionnaire 24 hour version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:clinical opiate withdrawal scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:clinical opiate withdrawal scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale already enrolled subjects questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale already enrolled subjects questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale baseline questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale baseline questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale baseline/screening version phase 1 study 1/14/09 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale children's baseline questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale children's baseline questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale children's baseline/screening questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale children's baseline/screening questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale children's since last visit questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale children's since last visit questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale lifetime/recent version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale lifetime/recent version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale pediatric/cognitively impaired - lifetime recent - clinical questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale screening questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale screening questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:columbia-suicide severity rating scale since last visit questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:columbia-suicide severity rating scale since last visit questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:contemplation ladder for smoking cessation --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:contemplation ladder for smoking cessation | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:copd assessment test questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:copd assessment test questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:craig handicap assessment and reporting technique - short form paper version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:craig handicap assessment and reporting technique - short form paper version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:craig handicap assessment and reporting technique-short form interview version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:craig handicap assessment and reporting technique-short form interview version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:current opioid misuse measure questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:current opioid misuse measure questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:dermatology life quality index questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:dermatology life quality index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:disability assessment for dementia questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:disability assessment for dementia questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:disability rating scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:disability rating scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:disease steps questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:disease steps questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:duke psychosocial questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:duke psychosocial questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:eastern cooperative oncology group performance status questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:eastern cooperative oncology group performance status questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:epworth sleepiness scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:epworth sleepiness scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:european organization for research and treatment of cancer quality of life questionnaire core 30 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:european organization for research and treatment of cancer quality of life questionnaire core 30 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:european quality of life five dimension five level scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:european quality of life five dimension five level scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:european quality of life five dimension three level questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:european quality of life five dimension three level questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:european quality of life five dimension three level youth questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:european quality of life five dimension three level youth questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:exacerbations of chronic pulmonary disease tool patient-reported outcome questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:expanded disability rating scale - postacute interview caregiver version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:expanded disability rating scale - postacute interview caregiver version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:expanded disability rating scale - postacute interview survivor version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:expanded disability rating scale - postacute interview survivor version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:expanded prostate cancer index composite --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:expanded prostate cancer index composite | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:expanded prostate cancer index composite for clinical practice questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:expanded prostate cancer index composite for clinical practice questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:expanded prostate cancer index composite, sexual medications/devices supplement --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:expanded prostate cancer index composite, sexual medications/devices supplement | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:faact questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:faact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:faces pain scale revised questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:faces pain scale revised questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-an questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-an questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-b+4 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-b+4 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-bl questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-bl questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-bmt questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-bmt questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-bp questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-bp questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-br questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-br questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-brm questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-brm questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-c questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-c questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-cns questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-cns questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-cognitive function --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-cognitive function | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-cx questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-cx questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-e questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-e questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-en questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-en questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-es questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-es questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-g questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-g questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-ga questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-ga questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-h&n questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-h&n questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-hep questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-hep questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-l questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-l questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-leu questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-leu questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-m questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-m questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-mm questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-mm questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-np questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-np questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-o questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-o questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-p questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-p questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-taxane questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-taxane questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact-th11 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact-th11 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fact/gog-ntx questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fact/gog-ntx questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:fait-u questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:fait-u questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:follow-up embodiment/outcomes questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:follow-up embodiment/outcomes questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:follow-up outcome expectations questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:follow-up outcome expectations questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional activities questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional activities questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional activities questionnaire-nacc version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional activities questionnaire-nacc version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional assessment of cancer therapy-general version 4 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of cancer therapy-general version 4 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional assessment of cancer therapy-prostate version 4 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of cancer therapy-prostate version 4 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of chronic illness therapy-fatigue version 4 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional assessment of human immunodeficiency virus infection --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of human immunodeficiency virus infection | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:functional assessment of multiple sclerosis questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:functional assessment of multiple sclerosis questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:generalized anxiety disorder - 7 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:generalized anxiety disorder - 7 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:generalized anxiety disorder questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:generalized anxiety disorder questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:geriatric depression scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:geriatric depression scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:geriatric depression scale short form questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:geriatric depression scale short form questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:global rating of change in joint pain and stiffness questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:global rating of change in joint pain and stiffness questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:health assessment questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:health assessment questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:health assessment questionnaire disability index questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:health assessment questionnaire disability index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:health assessment questionnaire-ii --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:health assessment questionnaire-ii | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:healthy volunteer medical history questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:healthy volunteer medical history questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire adult version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire adult version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire children's long version age group i --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire children's long version age group i | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire children's long version age group iii --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire children's long version age group iii | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire children's short version age group i --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire children's short version age group i | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire children's short version age group ii/iii --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire children's short version age group ii/iii | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire parent's long version age group i --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire parent's long version age group i | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire parent's long version age group ii --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire parent's long version age group ii | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hemophilia quality of life questionnaire parent's long version age group iii --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hemophilia quality of life questionnaire parent's long version age group iii | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:hospital anxiety and depression scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:hospital anxiety and depression scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:influenza intensity and impact questionnaire once daily version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:influenza intensity and impact questionnaire once daily version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:influenza intensity and impact questionnaire twice daily version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:influenza intensity and impact questionnaire twice daily version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:initial outcome satisfaction questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:initial outcome satisfaction questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:international index of erectile function questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:international index of erectile function questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:karnofsky performance status scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:karnofsky performance status scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:kaufman assessment battery for children --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:kaufman assessment battery for children | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:kurtzke expanded disability status scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:kurtzke expanded disability status scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:kurtzke functional systems scores questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:kurtzke functional systems scores questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:list of threatening experiences questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:list of threatening experiences questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:lymphedema and breast cancer questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:lymphedema and breast cancer questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:mayo-portland adaptability inventory-4 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:mayo-portland adaptability inventory-4 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:md anderson dysphagia inventory --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:md anderson dysphagia inventory | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:md anderson symptom inventory - brain tumor --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:md anderson symptom inventory - brain tumor | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:md anderson symptom inventory - head and neck --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:md anderson symptom inventory - head and neck | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:md anderson symptom inventory - lung chemoradiation --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:md anderson symptom inventory - lung chemoradiation | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:md anderson symptom inventory - spine tumor --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:md anderson symptom inventory - spine tumor | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:medical outcomes study physical functioning scale --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:medical outcomes study physical functioning scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:medical outcomes study social activities --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:medical outcomes study social activities | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:medical outcomes study social support survey --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:medical outcomes study social support survey | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:medical outcomes study your feelings questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:medical outcomes study your feelings questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:memorial symptom assessment scale --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:memorial symptom assessment scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:memorial symptom assessment scale - short form --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:memorial symptom assessment scale - short form | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:menstrual distress questionnaire form-t (today) --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:menstrual distress questionnaire form-t (today) | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:michigan neuropathy screening instrument questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:michigan neuropathy screening instrument questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:mini-mental status exam --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:mini-mental status exam | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:modified fatigue impact scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:modified fatigue impact scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:modified hachinski ischemic scale-nacc version questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:modified hachinski ischemic scale-nacc version questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:modified medical research council dyspnea scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:modified medical research council dyspnea scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:modified rankin scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:modified rankin scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:montgomery-asberg depression rating scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:montgomery-asberg depression rating scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:movement disorder society unified parkinson's disease rating scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:movement disorder society unified parkinson's disease rating scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:multidimensional body-self relations questionnaire appearance orientation --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:multidimensional body-self relations questionnaire appearance orientation | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:multinational association of supportive care in cancer antiemesis tool --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:multinational association of supportive care in cancer antiemesis tool | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:multiple sclerosis impact scale version 1 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:multiple sclerosis impact scale version 1 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:multiple sclerosis impact scale version 2 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:multiple sclerosis impact scale version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:multiple sclerosis quality of life-54 instrument questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:multiple sclerosis quality of life-54 instrument questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:myeloproliferative neoplasm symptom assessment form --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:myeloproliferative neoplasm symptom assessment form | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:national comprehensive cancer network/functional assessment of cancer therapy-prostate symptom index 17 version 2 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:neck dissection impairment index --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:neck dissection impairment index | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:neuropathic pain scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:neuropathic pain scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:nurses' health study ii activity and inactivity questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:nurses' health study ii activity and inactivity questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:older americans resource scale multidimensional functional assessment questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:older americans resource scale multidimensional functional assessment questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:parkinson's disease quality of life scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:parkinson's disease quality of life scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:patient determined disease steps questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient determined disease steps questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:patient health questionnaire - 15 item --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient health questionnaire - 15 item | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:patient health questionnaire screener version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient health questionnaire screener version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:patient health questionnaire-2 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient health questionnaire-2 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:patient satisfaction questionnaire short form --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:patient satisfaction questionnaire short form | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:pediatric quality of life inventory --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:pediatric quality of life inventory | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:perceived stress scale --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:perceived stress scale | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:prognosis treatment and perceptions questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:prognosis treatment and perceptions questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:promis adult sleep-related impairment item bank --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:promis adult sleep-related impairment item bank | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:prostate cancer specific quality of life instrument questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:prostate cancer specific quality of life instrument questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:quality of life questionnaire - testicular cancer 26 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:quality of life questionnaire - testicular cancer 26 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:rand 36-item health survey 1.0 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:rand 36-item health survey 1.0 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:raven's progressive matrices --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:raven's progressive matrices | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:rcc symptom index --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:rcc symptom index | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:rivermead post-concussion symptoms questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:rivermead post-concussion symptoms questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:roland morris disability questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:roland morris disability questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:screener and opioid assessment for patients with pain revised questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:screener and opioid assessment for patients with pain revised questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:sf-12 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:sf-12 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:sf-36 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:sf-36 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:sheehan disability scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:sheehan disability scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:short opiate withdrawal scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:short opiate withdrawal scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:st. george's respiratory questionnaire for chronic obstructive pulmonary disease patients | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:st. george's respiratory questionnaire past 4 weeks version --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:st. george's respiratory questionnaire past 4 weeks version | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:standards general clinical global impressions questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:standards general clinical global impressions questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:standards pain intensity questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:standards pain intensity questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:standards pain relief questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:standards pain relief questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:symptom impact questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:symptom impact questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:ten promis global health questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:ten promis global health questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:the oswestry disability index version 2.1a questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:the oswestry disability index version 2.1a questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:the overactive bladder questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:the overactive bladder questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:the overactive bladder questionnaire short form --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:the overactive bladder questionnaire short form | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:transition dyspnea index questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:transition dyspnea index questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:treatment satisfaction questionnaire for medication --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:treatment satisfaction questionnaire for medication | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:unified parkinson's disease rating scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:unified parkinson's disease rating scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:urgency perception scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:urgency perception scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:visual functioning questionnaire 25-self administered format version 2000 --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:visual functioning questionnaire 25-self administered format version 2000 | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:was it worth it questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:was it worth it questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:western ontario and mcmaster universities osteoarthritis index version 3.1 numerical rating scale format questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:work productivity and activity impairment specific health problems version 2.0 questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:work productivity and activity impairment specific health problems version 2.0 questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 en:young mania rating scale questionnaire --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=en:young mania rating scale questionnaire | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 rein --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=rein | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20 thérapie --- r_associated #0: 20 --> en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire n1=thérapie | n2=en:national comprehensive cancer network/functional assessment of cancer therapy-kidney symptom index-19 version 2 questionnaire | rel=r_associated | relid=0 | w=20